MarkBernardZimeringMD

PubMed

• Reversal of Early Increased Anxiety-Like Behavior in the Zucker FattyLean Rat: Possible Role of Acquired Hormonal Factors.
  Mihal Grinberg, Mark B Zimering> ;Endocrinology, Diabetes and Metabolism Journal. 2023 Jun 1
• A Serotonin 2A-Receptor Decoy Peptide Potently Lowers Blood Pressure in Male Zucker Diabetic, Fatty, Hypertensive Rats.
  Mark B Zimering> ;Endocrinology, Diabetes and Metabolism Journal. 2021 Aug 1
• 2 citations
  Circulating IgGs in Type 2 Diabetes with Atrial Fibrillation Induce IP3-Mediated Calcium Elevation in Cardiomyocytes.
  Yanhong Luo, Xian Liu, Ruilian Ma, Yigang Wang, Mark B Zimering, Zui Pan> ;Iscience. 2020 Apr 8
• Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but ...
  Mark B Zimering, John J Shin, Jennifer D Zaitz, Elkin A Nunez, Andrew G. Gianoukakis> ;Endocrinology, Diabetes and Metabolism Journal. 2019 Jan 8
• Increased Neuronal Depolarization Evoked by Autoantibodies in Diabetic Obstructive Sleep Apnea: Role for Inflammatory Protease(s) in Generation of Neurotoxic Immunoglo...
  Zimering, M. B., Pan, Z.> ;Journal of endocrinology and diabetes. 2017 Jan 1
• Toxic Immunoglobulin Light Chain Autoantibodies are Associated with a Cluster of Severe Complications in Older Adult Type 2 Diabetes.
  Zimering, M. B., Zimering, M. B., Mirkovic, N., Mirkovic, N., Pandya, M., Pandya, M., Zimering, J. H., Zimering, J. H., Behnke, J. A., Behnke, J. A., Thakker-Varia, S....> ;Journal of endocrinology and diabetes.
• 6 citations
  Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.
  Mark B Zimering, Jane H. Zhang, Peter Guarino, Nicholas V. Emanuele, Peter A. McCullough, Linda F. Fried> ;Frontiers in Endocrinology. 2014 Aug 11
• 5 citations
  Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial.
  Mark B Zimering, Robert J. Anderson, Ling Ge, Thomas E. Moritz, William C. Duckworth> ;Frontiers in Endocrinology. 2013 Nov 22
• 11 citations
  Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementia.
  Mark B Zimering, Thomas E. Moritz, Robert J. Donnelly> ;Frontiers in Endocrinology. 2013 May 15
• 19 citations
  Anti-endothelial and anti-neuronal effects from auto-antibodies in subsets of adult diabetes having a cluster of microvascular complications.
  Mark B Zimering, Janet Alder, Zui Pan, Robert J. Donnelly> ;Diabetes Research and Clinical Practice. 2011 Jul 1
• 13 citations
  Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus.
  Zimering, M. B., Anderson, R. J., Ge, L., Moritz, T. E.> ;Metabolism: clinical and experimental.
• 31 citations
  Autoantibodies in type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells.
  Mark B Zimering, Zui Pan> ;The Journal of Clinical Endocrinology and Metabolism. 2009 May 1
• 8 citations
  Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes Trial.
  Mark B Zimering, Robert J. Anderson, Thomas E. Moritz, Ling Ge> ;Metabolism. 2009 Jun 1
• 10 citations
  Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial.
  Mark B Zimering, Robert J. Anderson, Thomas E. Moritz, Ling Ge> ;Metabolism. 2009 Mar 1
• 2 citations
  Neurotrophic effects of fibroblast growth factor-like autoantibodies in serum from three patients with breast cancer.
  Mark B Zimering, Janet Alder, Smita Thakker-Varia> ;Brain Research. 2009 Jan 28
• 6 citations
  Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial.
  Mark B Zimering, Robert J. Anderson, Ping Luo, Thomas E. Moritz> ;Metabolism. 2008 Nov 1
• 174 citations
  Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia
  Erik A. Imel, Munro Peacock, Pisit Pitukcheewanont, Howard J. Heller, Leanne M Ward, Dorothy I. Shulman, Moustapha Kassem, Paula J. Rackoff, Mark B Zimering, Alan C. D...> ;The Journal of Clinical Endocrinology and Metabolism. 2006 Jun 1
• 26 citations
  Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
  Mark B Zimering, Felice A. Caldarella, Kenneth E. White, Michael J. Econs> ;Endocrine Practice. 2005 Mar 1
• 22 citations
  Increased fibroblast growth factor-like autoantibodies in serum from a subset of patients with cancer-associated hypercalcemia.
  Mark B Zimering, Smita Thakker-Varia> ;Life Sciences. 2002 Nov 8
• 18 citations
  Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in serum of patients with cancer-associated hypercalcemia ☆
  Mark B Zimering> ;Life Sciences. 2002 Mar 8
• 4 citations
  Fibroblast Growth Factor?like Autoantibodies in Plasma from Patients with Multiple Endocrine Neoplasia Type 1 and Prolactinoma
  Mark B Zimering, N. Katsumata, H. G. Friesen, J. Eng, D. J. Riley, Smita Thakker-Varia, Stephen J. Marx, S. Ezzat> ;Annals of the New York Academy of Sciences. 1997 Apr 1
• 32 citations
  Increased Basic Fibroblast Growth Factor-Like Substance in Plasma from a Subset of Middle-Aged or Elderly Male Diabetic Patients with Microalbuminuria or Proteinuria*
  Mark B Zimering, John Eng> ;The Journal of Clinical Endocrinology and Metabolism. 1996 Dec 1
• 11 citations
  Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma.
  Mark B Zimering, D J Riley, S Thakker-Varia, A M Walker, V Lakshminaryan, R Shah, M L Brandi, S Ezzat, N Katsumata, H G Friesen> ;The Journal of Clinical Endocrinology and Metabolism. 1994 Dec 1
• Join now to see all